Shionogi will acquire IntraBio for $2 billion
Statements (3)
- Bullish
Shionogi is acquiring IntraBio for US$ 2 billion to strengthen its rare disease area
- Bullish
Shionogi approved an agreement to acquire IntraBio Inc.
- Bullish
Shionogi will acquire IntraBio for $2 billion